Home Advaxis's Listeria-based Lm-LLO Immunotherapy Featured in Nature Biotechnology
 

Keywords :   


Advaxis's Listeria-based Lm-LLO Immunotherapy Featured in Nature Biotechnology

2014-12-11 14:21:39| Biotech - Topix.net

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, announced today that its Lm -LLO immunotherapy technology is featured in an article in the December 2014 issue of Nature Biotechnology . Entitled " Listeria vaccines join the checkpoint frenzy," the article explores the potential of the Listeria bacterium as a vector to enhance an anti-tumor response given its ability to induce powerful innate and adaptive immune responses.

Tags: featured nature biotechnology immunotherapy

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11NIKE13FG
24.11adidas
24.11NIKE
24.116
24.11 (UK)CAP
24.11 (
24.11tt011/10 rc
24.11dorachama Lysin 32kg
More »